The Relationship of Omental and Subcutaneous Adipocyte Size to Metabolic Disease in Severe Obesity
Open accessThe DOI matches its Crossref record; 46 of the 47 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Several studies have reported the existence of a subgroup of obese individuals with normal metabolic profiles. It remains unclear what factors are responsible for this phenomenon. We proposed that adipocyte size might be a key factor in the protection of metabolically healthy obese (MHO) individuals from the adverse effects of obesity. SUBJECTS: Thirty-five patients undergoing bariatric surgery were classified as MHO (n = 15) or metabolically unhealthy obese (MUO, n = 20) according to cut-off points adapted from the International Diabetes Federation definition of the metabolic syndrome. Median body mass index (BMI) was 48 (range 40-71). RESULTS: There was a moderate correlation between omental adipocyte size and subcutaneous adipocyte size (r = 0.59, p<0.05). The MHO group had significantly lower mean omental adipocyte size (80.9+/-10.9 microm) when compared with metabolically unhealthy patients (100.0+/-7.6 microm, p<0.0001). Mean subcutaneous adipocyte size was similar between the two groups (104.1+/-8.5 microm versus 107.9+/-7.1 microm). Omental, but not subcutaneous adipocyte size, correlated with the degree of insulin resistance as measured by HOMA-IR (r = 0.73, p<0.0005), as well as other metabolic parameters including triglyceride/HDL-cholesterol ratio and HbA1c. Twenty-eight patients consented to liver biopsy. Of these, 46% had steatohepatitis and fibrosis. Fifty percent (including all the MHO patients) had steatosis only. Both omental and subcutaneous adipocyte size were significantly associated with the degree of steatosis (r = 0.66, p<0.0001 and r = 0.63, p<0.005 respectively). However, only omental adipocyte size was an independent predictor of the presence or absence of fibrosis. CONCLUSION: Metabolically healthy individuals are a distinct subgroup of the severely obese. Both subcutaneous and omental adipocyte size correlated positively with the degree of fatty liver, but only omental adipocyte size was related to metabolic health, and possibly progression from hepatic steatosis to fibrosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Demographics ranging between men, women, and postmenopausal women show that there is a correlation between a beneficial phenotype for metabolic outcomes and subcutaneous fat accumulation, whereas visceral fat accumulation, including omental adipocyte hypertrophy, leads to a decline in metabolic health (20–25).”
From Metabolic impact of endogenously produced estrogens by adipose tissue in females and males across the lifespan (2025) · cites this paper as [23]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041 · cited 1×
“However, larger adipocytes are positively correlated with adipose tissue macrophage number and production of pro-inflammatory cytokines TNF-a and IL-6 in mice[42].”
BackgroundAdipose Tissue as an Endocrine Organ
Kershaw, E. E., & Flier, J. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0395 · Cited by 5,522
Steatohepatitis: A tale of two “hits”?
Day, C. P., & James, O. F. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70599-2 · Cited by 4,285 · cited 1×
“‘two hit’ hypothesis for steatohepatitis[46].”
Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome
Wajchenberg, B. L. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.6.0415 · Cited by 2,961 · cited 1×
“Depot-related differences exist in adipocyte responses to lipolytic and lipogenic stimuli, in adipocyte apoptosis, expression of adipokine receptors, and secretion of adipokines[13,14,15,16].”
BackgroundIndependent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis
Angulo, P., Keach, J. C., Batts, K. P., & Lindor, K. D. (1999) · Hepatology · doi:10.1002/hep.510300604 · Cited by 1,610 · cited 1×
“Recent studies indicate that the histological severity of NAFLD correlates with the indices of the metabolic syndrome, particularly degree of insulin resistance[40,41].”
BackgroundRelationship between Adipocyte Size and Adipokine Expression and Secretion
Skurk, T., Alberti-Huber, C., Herder, C., & Hauner, H. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1055 · Cited by 1,288 · cited 2×
“Large adipocytes are more likely to produce pro-inflammatory adipokines[12] and to demonstrate increased basal and catecholamine-stimulated lipolysis[24].”
BackgroundScherer, P. E. (2006) · Diabetes · doi:10.2337/db06-0263 · Cited by 1,066
Identification and characterization of metabolically benign obesity in humans
Stefan, N. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.15.1609 · Cited by 1,049 · cited 4×
“Other studies have investigated the factors responsible for protecting MHO individuals from developing co-morbidities such as diabetes and dyslipidemia[4,5,6].”
BackgroundInfluentialWeyer, C., Foley, J. E., Bogardus, C., Tataranni, P. A., & Pratley, R. E. (2000) · Diabetologia · doi:10.1007/s001250051560 · Cited by 799
Gender differences in fat metabolism
Blaak, E. (2001) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/00075197-200111000-00006 · Cited by 709 · cited 1×
“women than in men, whereas free fatty acid release from the upper body depots is comparable[38].”
BackgroundMcLaughlin, T., Reaven, G., Abbasi, F., Lamendola, C., Saad, M., Waters, D., Simon, J., & Krauss, R. M. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.03.085 · Cited by 658 · cited 1×
“The plasma triglyceride/high-density lipoprotein cholesterol concentration ratio was used as this has been shown to provide a simple means of identifying insulin-resistant, dyslipidemic patients who are likely to be at increased risk of cardiovascular disease[20].”
MethodAdipocyte Turnover: Relevance to Human Adipose Tissue Morphology
Arner, E., Westermark, P. O., Spalding, K. L., Britton, T., Rydén, M., Frisén, J., Bernard, S., & Arner, P. (2010) · Diabetes · doi:10.2337/db09-0942 · Cited by 645 · cited 1×
“In the setting of extremely obese individuals, as in our cohort, the subcutaneous adipocytes may all have reached their maximum expansion limit, and therefore MHO and MUO have similar mean adipocyte size. However, MHO may have increased pre-adipocyte and adipocyte number, and therefore overall greater subcutaneous sto…”
BackgroundCancello, R., Tordjman, J., Poitou, C., Guilhem, G., Bouillot, J. L., Hugol, D., Coussieu, C., Basdevant, A., Hen, A. B., Bedossa, P., et al. (2006) · Diabetes · doi:10.2337/db06-0133 · Cited by 607 · cited 1×
“Omental macrophage accumulation is also associated with the severity of fibroinflammatory liver damage, independently of degree of insulin resistance[43,44].”
BackgroundSalans, L. B., Knittle, J. L., & Hirsch, J. (1968) · Journal of Clinical Investigation · doi:10.1172/jci105705 · Cited by 582 · cited 2×
“Over 4 decades ago, adipocyte size was shown to vary inversely with adipocyte insulin sensitivity[9].”
BackgroundThe metabolically healthy but obese individual presents a favorable inflammation profile
Karelis, A. D., Faraj, M., Bastard, J.-P., St-Pierre, D. H., Brochu, M., Prud’homme, D., & Rabasa-Lhoret, R. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0482 · Cited by 579 · cited 2×
“Other studies have investigated the factors responsible for protecting MHO individuals from developing co-morbidities such as diabetes and dyslipidemia[4,5,6].”
BackgroundThe “metabolically-obese,” normal-weight individual
Ruderman, N. B., Schneider, S. H., & Berchtold, P. (1981) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/34.8.1617 · Cited by 545 · cited 1×
“protected from the increased morbidity and mortality associated with excess weight[1,2,3].”
BackgroundIncreases in Clinically Severe Obesity in the United States, 1986-2000
Sturm, R. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.18.2146 · Cited by 542 · cited 1×
“Few studies have focused on individuals with a body mass index (BMI) >40, the fastest growing category of obesity”
BackgroundBays, H. E., González-Campoy, J. M., Bray, G. A., Kitabchi, A. E., Bergman, D. A., Schorr, A. B., Rodbard, H. W., & Henry, R. R. (2008) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.6.3.343 · Cited by 530 · cited 1×
“The primary defect may be an inability of subcutaneous adipose tissue proliferation and differentiation[27,28].”
BackgroundAdipose Tissue Quantification by Imaging Methods: A Proposed Classification
Shen, W., Wang, Z., Punyanita, M., Lei, J., Sinav, A., Kral, J. G., Imielinska, C., Ross, R., & Heymsfield, S. B. (2003) · Obesity Research · doi:10.1038/oby.2003.3 · Cited by 509 · cited 1×
“Intra-peritoneal visceral fat can also be subdivided into omental and mesenteric fat[33], with emerging evidence that mesenteric adipose tissue has a distinct role in the insulin resistance of diabetes and the metabolic syndrome[34,35,36].”
BackgroundLiver Fat in the Metabolic Syndrome
Kotronen, A., Westerbacka, J., Bergholm, R., Pietiläinen, K. H., & Yki-Järvinen, H. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0482 · Cited by 457 · cited 1×
“Also, the anatomic location of visceral adipose tissue means that fatty acids are released directly into the portal circulation and fat accumulation in the liver has been shown to be an important feature of the metabolic syndrome[17,18].”
BackgroundSeparation of human adipocytes by size: hypertrophic fat cells display distinct gene expression
Jernås, M., Palming, J., Sjöholm, K., Jennische, E., Svensson, P.-A., Gabrielsson, B. G., Levin, M., Sjögren, A., Rudemo, M., Lystig, T. C., et al. (2006) · The FASEB Journal · doi:10.1096/fj.05-5678fje · Cited by 454 · cited 2×
“Large adipocytes also have altered gene expression profiles when compared with smaller adipocytes[10].”
BackgroundBrochu, M., Tchernof, A., Dionne, I. J., Sites, C. K., Eltabbakh, G. H., Sims, E. A. H., & Poehlman, E. T. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.3.7365 · Cited by 443 · cited 3×
“Other studies have investigated the factors responsible for protecting MHO individuals from developing co-morbidities such as diabetes and dyslipidemia[4,5,6].”
BackgroundHeilbronn, L., Smith, S. R., & Ravussin, E. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802853 · Cited by 412 · cited 1×
“The primary defect may be an inability of subcutaneous adipose tissue proliferation and differentiation[27,28].”
BackgroundLipid overload and overflow: metabolic trauma and the metabolic syndrome
UNGER, R. (2003) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2003.09.008 · Cited by 401 · cited 1×
“Excess fatty acids then ‘overflow’ to ectopic sites, including muscle and liver, leading to peripheral and hepatic insulin resistance, respectively[22,23].”
BackgroundSniderman, A. D., Bhopal, R., Prabhakaran, D., Sarrafzadegan, N., & Tchernof, A. (2007) · International Journal of Epidemiology · doi:10.1093/ije/dyl245 · Cited by 343 · cited 1×
“Excess fatty acids then ‘overflow’ to ectopic sites, including muscle and liver, leading to peripheral and hepatic insulin resistance, respectively[22,23].”
BackgroundNonalcoholic fatty liver disease: A manifestation of the metabolic syndrome
KIM, C. H., & YOUNOSSI, Z. M. (2008) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.75.10.721 · Cited by 340 · cited 1×
“Also, the anatomic location of visceral adipose tissue means that fatty acids are released directly into the portal circulation and fat accumulation in the liver has been shown to be an important feature of the metabolic syndrome[17,18].”
BackgroundHistological assessment of non‐alcoholic fatty liver disease
Hübscher, S. G. (2006) · Histopathology · doi:10.1111/j.1365-2559.2006.02416.x · Cited by 292 · cited 1×
“ballooning degeneration with Mallory’s hyaline, neutrophilic infiltration and perisinusoidal or pericellular fibrosis[21].”
BackgroundTchkonia, T., Tchoukalova, Y. D., Giorgadze, N., Pirtskhalava, T., Karagiannides, I., Forse, R. A., Koo, A., Stevenson, M., Chinnappan, D., Cartwright, A., et al. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00265.2004 · Cited by 254 · cited 1×
“Intra-peritoneal visceral fat can also be subdivided into omental and mesenteric fat[33], with emerging evidence that mesenteric adipose tissue has a distinct role in the insulin resistance of diabetes and the metabolic syndrome[34,35,36].”
BackgroundPalekar, N. A., Naus, R., Larson, S. P., Ward, J., & Harrison, S. A. (2006) · Liver International · doi:10.1111/j.1478-3231.2005.01209.x · Cited by 216 · cited 1×
“Recent studies indicate that the histological severity of NAFLD correlates with the indices of the metabolic syndrome, particularly degree of insulin resistance[40,41].”
BackgroundWinkler, G., Kiss, S., Keszthelyi, L., Sapi, Z., Ory, I., Salamon, F., Kovacs, M., Vargha, P., Szekeres, O., Speer, G., et al. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1490129 · Cited by 213
Effect of obesity on total mortality.
Andres, R. (1980) · PubMed · Cited by 207
Adipocyte size predicts incidence of type 2 diabetes in women
Lönn, M., Mehlig, K., Bengtsson, C., & Lissner, L. (2010) · The FASEB Journal · doi:10.1096/fj.09-133058 · Cited by 207 · cited 1×
“Lonn M et al showed that abdominal subcutaneous adipocyte size predicted the onset of DM2 independently of body fat percentage or waist to hip ratio in a Swedish cohort of women[25].”
BackgroundSubcutaneous adipocyte size and body fat distribution
Tchoukalova, Y. D., Koutsari, C., Karpyak, M. V., Votruba, S. B., Wendland, E., & Jensen, M. D. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.1.56 · Cited by 204 · cited 3×
“This could account for the differences between our findings, and those of other studies reporting associations between subcutaneous adipocyte size and metabolic risk, where the mean BMI of populations studied is usually 25– 30 kg/m(2) [31,37].”
BackgroundResultYang, X., & Smith, U. (2007) · Diabetologia · doi:10.1007/s00125-007-0640-1 · Cited by 194 · cited 1×
“Depot-related differences exist in adipocyte responses to lipolytic and lipogenic stimuli, in adipocyte apoptosis, expression of adipokine receptors, and secretion of adipokines[13,14,15,16].”
BackgroundAdiponectin Receptors in Human Adipose Tissue: Effects of Obesity, Weight Loss, and Fat Depots
Rasmussen, M. S., Lihn, A. S., Pedersen, S. B., Bruun, J. M., Rasmussen, M., & Richelsen, B. (2006) · Obesity · doi:10.1038/oby.2006.5 · Cited by 160 · cited 1×
“Depot-related differences exist in adipocyte responses to lipolytic and lipogenic stimuli, in adipocyte apoptosis, expression of adipokine receptors, and secretion of adipokines[13,14,15,16].”
BackgroundPrevalence of Uncomplicated Obesity in an Italian Obese Population
Iacobellis, G., Ribaudo, M. C., Zappaterreno, A., Iannucci, C. V., & Leonetti, F. (2005) · Obesity Research · doi:10.1038/oby.2005.130 · Cited by 152 · cited 2×
“Several papers support the concept of metabolically healthy obese (MHO) individuals and investigate what factors characterize this phenotype[3,4,5,6].”
BackgroundFat Depot‐specific Impact of Visceral Obesity on Adipocyte Adiponectin Release in Women
Drolet, R., Bélanger, C., Fortier, M., Huot, C., Mailloux, J., Légaré, D., & Tchernof, A. (2009) · Obesity · doi:10.1038/oby.2008.555 · Cited by 131
Tordjman, J., Poitou, C., Hugol, D., Bouillot, J., Basdevant, A., Bédossa, P., Guerre-Millo, M., & Clément, K. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.02.031 · Cited by 117 · cited 1×
“Omental macrophage accumulation is also associated with the severity of fibroinflammatory liver damage, independently of degree of insulin resistance[43,44].”
BackgroundIntestinal, adipose, and liver inflammation in diet-induced obese mice
Li, H., Lelliott, C. J., Håkansson, P., Ploj, K., Tuneld, A., Verolin-Johansson, M., Benthem, L., Carlsson, B., Storlien, L. H., & Michaëlsson, E. (2008) · Metabolism · doi:10.1016/j.metabol.2008.07.029 · Cited by 116 · cited 1×
“Intra-peritoneal visceral fat can also be subdivided into omental and mesenteric fat[33], with emerging evidence that mesenteric adipose tissue has a distinct role in the insulin resistance of diabetes and the metabolic syndrome[34,35,36].”
BackgroundEffect of cell size on lipolysis and antilipolytic action of insulin in human fat cells
Jacobsson, B., & Smith, U. (1972) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39370-6 · Cited by 109
Franck, N., Stenkula, K. G., Öst, A., Lindström, T., Strålfors, P., & Nyström, F. H. (2007) · Diabetologia · doi:10.1007/s00125-007-0713-1 · Cited by 104 · cited 1×
“and a blunting of GLUT-4 translocation in response to insulin stimulation in larger adipocytes”
BackgroundYang, Y.-K., Chen, M., Clements, R. H., Abrams, G. A., Aprahamian, C. J., & Harmon, C. M. (2008) · Cellular Physiology and Biochemistry · doi:10.1159/000185527 · Cited by 100 · cited 1×
“Intra-peritoneal visceral fat can also be subdivided into omental and mesenteric fat[33], with emerging evidence that mesenteric adipose tissue has a distinct role in the insulin resistance of diabetes and the metabolic syndrome[34,35,36].”
BackgroundSteatohepatitis in obese individuals
Youssef, W. I., & McCullough, A. J. (2002) · Best Practice & Research Clinical Gastroenterology · doi:10.1053/bega.2002.0334 · Cited by 96 · cited 1×
“In the setting of severe obesity, the prevalence of NAFLD ranges from 75– 85%[39].”
BackgroundImbeault, P., Lemieux, S., Prud’homme, D., Tremblay, A., Nadeau, A., Després, J., & Mauriège, P. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90085-9 · Cited by 77 · cited 1×
“This could account for the differences between our findings, and those of other studies reporting associations between subcutaneous adipocyte size and metabolic risk, where the mean BMI of populations studied is usually 25– 30 kg/m(2) [31,37].”
ResultJensen, M. D., & Johnson, C. M. (1996) · Metabolism · doi:10.1016/s0026-0495(96)90040-2 · Cited by 70 · cited 1×
“Previous work has demonstrated morphological and metabolic differences between abdominal, gluteal and femoral subcutaneous adipose tissue depots[30,31,32].”
BackgroundSex differences in abdominal, gluteal, and thigh LPL activity
Votruba, S. B., & Jensen, M. D. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00601.2006 · Cited by 37 · cited 3×
“The relationship between fat cell size and lipoprotein lipase activity is similar in males and females in abdominal fat but not gluteal fat[30].”
Background
Cited by
Inflammatory links between obesity and metabolic disease
Lumeng, C. N., & Saltiel, A. R. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57132 · Cited by 2,319
Adipose tissue inflammation and metabolic dysfunction in obesity
Kawai, T., Autieri, M. V., & Scalia, R. (2021) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00379.2020 · Cited by 1,947
Adipose Tissue Remodeling: Its Role in Energy Metabolism and Metabolic Disorders
Choe, S. S., Huh, J. Y., Hwang, I. J., Kim, J. I., & Kim, J. B. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00030 · Cited by 1,206
“A frequent feature of the MHO population is a lower number of immune cells and a higher proportion of relatively small adipocytes in adipose tissues (77, 114, 115, 117).”
BackgroundChronic Adipose Tissue Inflammation Linking Obesity to Insulin Resistance and Type 2 Diabetes
Zatterale, F., Longo, M., Naderi, J., Raciti, G. A., Desiderio, A., Miele, C., & Beguinot, F. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2019.01607 · Cited by 1,180
“Cross-sectional studies have demonstrated that the size of visceral adipocytes is negatively correlated with insulin sensitivity (O’Connell et al., 2010; Hardy et al., 2011), and these findings allow proposing adipocyte size as an IR determinant (O’Connell et al.”
BackgroundSamson, S. L., & Garber, A. J. (2014) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.09.009 · Cited by 746
Metadata
- Authors
- O'Connell, J., Lynch, L., Cawood, T. J., Kwasnik, A., Nolan, N., Geoghegan, J., McCormick, A., O'Farrelly, C., & O'Shea, D.
- Affiliations
- St. Vincent's University Hospital (IE)
- Christchurch Hospital (NZ)
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-04-01
- Volume
- 5
- Issue
- 4
- Pages
- e9997
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC2848665
- OpenAlex
- W2115664664
- Cited by
- 211
- References
- 47
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 11 · 2023: 4 · 2022: 14 · 2021: 14 · 2020: 19 · 2019: 16 · 2018: 11 · 2017: 11 · 2016: 16 · 2015: 18 · 2014: 19 · 2013: 18 · 2012: 9
- FWCI
- 11.08
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Arrow@dit (Dublin Institute of Technology) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Trinity's Access to Research Output (TARA) (Trinity College Dublin) (submittedVersion)
- Lenus, The Irish Health Repository (Dr Steevens Hospital Library) (submittedVersion)
- Funders
- Medical Research Charities Group
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Keywords
- metabolically healthy obesity, omental adipocytes, subcutaneous adipocytes, adipocyte size, morbid obesity, insulin resistance, hepatic steatosis, liver fibrosis, steatohepatitis, bariatric surgery, metabolic syndrome, HOMA-IR
- MeSH terms
- Adult, Fatty Liver, Female, Humans, Insulin Resistance, Male, Metabolic Diseases, Middle Aged, Omentum, Body Mass Index, Adipocytes, Metabolic Syndrome, Cell Size, Subcutaneous Fat
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.